Asia At Center Of Type 2 Diabetes Storm
This article was originally published in PharmAsia News
Executive Summary
India and China remain at the center of a diabetes storm in Asia with type 2 cases showing up among a younger population at a faster pace than Western counterparts. International diabetes expert Gregory Fulcher sat down with PharmAsia News on the sidelines of the 10th International Diabetes Federation-Western Pacific Region held jointly with the 6th Asian Association for the Study of Diabetes Meeting in Singapore in November and discussed the outlook for treatment and diagnostics.
You may also be interested in...
List Ahead For Southeast Asia Pharma In 2015
PharmAsia News looks ahead at 2015 to highlight expected trends and events shaping the biomedical community in Southeast Asia.
Southeast Asia 2014: Distribution, Manufacturing To The Fore
Southeast Asia in 2014 saw a continued push by several nations in the region to ink a Trans-Pacific Partnership pact that would potentially have a major impact on biological drugs. Also manufacturing and distribution saw a leap in the hub of Singapore as governments in the region ramped-up health spending.
Asia caught in the eye of a diabetes storm
Asia now shoulders 63% of the world’s type 2 diabetes burden, with around 202 million cases in total and a younger onset age than the Western population. Most of these cases are in China and India, while the national prevalence of type 2 diabetes has also increased two-fold or more in many Asian countries, according to data gathered for the 10th International Diabetes Federation-Western Pacific Region held jointly with the 6th Asian Association for the Study of Diabetes in Singapore in late November.